p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status
- PMID: 20588174
- PMCID: PMC3873742
- DOI: 10.1097/PAS.0b013e3181e84652
p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status
Abstract
Background: In the human papillomavirus (HPV) era, the best way to assess oropharyngeal squamous carcinomas (SCC) for risk stratification is not clear. Many recommend use of both p16 immunohistochemistry and HPV in situ hybridization (ISH). A significant minority of tumors are p16 positive and HPV ISH negative, the significance of which is unclear.
Methods: Two hundred thirty-nine oropharyngeal SCC were tested by immunohistochemistry for p16 and by ISH for high-risk HPV. For p16 positive, HPV ISH negative cases, PCR was conducted for HPV. The findings were correlated with pathologic and clinical findings.
Results: Of the 239 cases, 187 (78%) were positive for p16. Of these, 139 (74%) were positive for HPV by ISH. Of the remaining 48 cases, 45 had material for PCR. Nineteen were positive for HPV, leaving a group of 26 p16 positive and HPV undetectable SCCs. In the p16 positive cohort, there was no difference in survival between HPV ISH positive and negative cases. Comparing the HPV ISH positive and HPV ISH and PCR negative SCC, there was again no difference in survival. p16 positive, HPV negative SCC still had significantly better survival than p16 negative SCC in univariate and multivariate analysis.
Conclusions: Outcomes for p16 positive, HPV negative oropharyngeal SCC are not significantly different from p16 positive, HPV positive tumors and are significantly better than for p16 negative tumors. These results suggest that p16 immunohistochemistry alone is the best test to use for risk stratification in oropharyngeal SCC.
Figures






Comment in
-
Isolating p16-positive/HPV-negative oropharyngeal cancer: an effort worth making.Am J Surg Pathol. 2011 May;35(5):774-7; author reply 777-8. doi: 10.1097/PAS.0b013e3182116a45. Am J Surg Pathol. 2011. PMID: 21436677 No abstract available.
Similar articles
-
High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.Am J Surg Pathol. 2011 Sep;35(9):1343-50. doi: 10.1097/PAS.0b013e318220e59d. Am J Surg Pathol. 2011. PMID: 21836494
-
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697079 Free PMC article. Clinical Trial.
-
p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.Mod Pathol. 2017 Sep;30(9):1194-1203. doi: 10.1038/modpathol.2017.31. Epub 2017 Jun 16. Mod Pathol. 2017. PMID: 28621317
-
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Int J Cancer. 2017 Mar 1;140(5):1186-1198. doi: 10.1002/ijc.30516. Epub 2016 Dec 2. Int J Cancer. 2017. PMID: 27859245 Review.
-
Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review.Br J Cancer. 2014 Mar 18;110(6):1587-94. doi: 10.1038/bjc.2014.42. Epub 2014 Feb 11. Br J Cancer. 2014. PMID: 24518594 Free PMC article. Review.
Cited by
-
P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.Virchows Arch. 2015 Apr;466(4):375-82. doi: 10.1007/s00428-015-1725-8. Epub 2015 Feb 5. Virchows Arch. 2015. PMID: 25652585
-
Expression of human papillomavirus-related proteins and its clinical implication in tonsillar squamous cell carcinoma.Korean J Pathol. 2012 Apr;46(2):177-86. doi: 10.4132/KoreanJPathol.2012.46.2.177. Epub 2012 Apr 25. Korean J Pathol. 2012. PMID: 23109998 Free PMC article.
-
Expression of p16Ink4a protein in pleomorphic adenoma and carcinoma ex pleomorphic adenoma proves diversity of tumour biology and predicts clinical course.J Clin Pathol. 2022 Sep;75(9):605-611. doi: 10.1136/jclinpath-2021-207440. Epub 2021 May 3. J Clin Pathol. 2022. PMID: 33941588 Free PMC article.
-
Genome stability pathways in head and neck cancers.Int J Genomics. 2013;2013:464720. doi: 10.1155/2013/464720. Epub 2013 Nov 4. Int J Genomics. 2013. PMID: 24364026 Free PMC article. Review.
-
Tumor risk markers in recurrent respiratory papillomatosis.Braz J Otorhinolaryngol. 2023 Mar-Apr;89(2):285-291. doi: 10.1016/j.bjorl.2022.10.049. Epub 2022 Oct 20. Braz J Otorhinolaryngol. 2023. PMID: 36319567 Free PMC article.
References
-
- Adelstein DJ. Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions. Int J Radiat Oncol Biol Phys. 2007;69:S37–S39. - PubMed
-
- Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting; Head Neck; November 9–10, 2008; Washington, D.C. 2009. pp. 1393–1422. - PubMed
-
- Alos L, Castillo M, Nadal A, et al. Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases. Histopathology. 2004;44:570–579. - PubMed
-
- Begum S, Cao D, Gillison M, et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2005;11:5694–5699. - PubMed
-
- Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044–1050. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials